4021:TYO
Nissan Chemical Corp
Â¥8,392.00
arrow_downward
-0.73%(-62.00) 1D
Oct 2, 3:30:00 PM GMT+9 · JPY
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4021...
Open
Â¥8,403
High
Â¥8,416
Low
Â¥8,314
Mkt. cap
1.13T
Avg. vol.
576.38K
Volume
483.30K
Dividend
2.41%
Quarterly dividend
Â¥51
Ex-dividend date
Sep 29, 2026
P/E ratio
21.42
52-wk high
Â¥8,707
52-wk low
Â¥4,864
EPS
Â¥392
Shares outstanding
148.49M
No. of employees
3K
Open
Â¥8,403
High
Â¥8,416
Low
Â¥8,314
Mkt. cap
1.13T
Avg. vol.
576.38K
Volume
483.30K
Dividend
2.41%
Quarterly dividend
Â¥51
Ex-dividend date
Sep 29, 2026
P/E ratio
21.42
52-wk high
Â¥8,707
52-wk low
Â¥4,864
EPS
Â¥392
Shares outstanding
148.49M
No. of employees
3K
News stories
From web sources and news partners
Forbes
·
24 minutes ago
S&P 500 Q3 Earnings Preview: Trends Investors Need To Watch
24/7 Wall St.
·
1 hour ago
Why Pay to Own U.S. Stocks? This Zero-Fee ETF Is Beating the S&P 500
AOL.com
·
1 hour ago
History Says Stocks Typically Fall After a Fed Hike Cycle Begins -- Then Gain 6.8% Within a Year. Here's My Plan.
The Motley Fool
·
1 hour ago
The S&P 500 Hasn't Looked This Cheap Based on a Popular Metric in Decades. Should You Buy Stocks Now?
Profile
Nissan Chemical Corporation is a Japanese company and constituent of the Nikkei 225 stock index. Wikipedia
About Nissan Chemical Corp
CEOKojiro Kinoshita
Employees3.41K
Founded1887
Headquarters-
SectorChemical industry
Websitenissanchem.co.jp
Last report
Aug 7, 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
78.79B / 73.58B
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in JPY | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 60.22B | 65.34B | 84.15B | 78.79B |
Cost of goods sold | 32.48B | 33.15B | 47.25B | 38.96B |
Cost of revenue | 32.48B | 33.15B | 47.25B | 38.96B |
Research and development expenses | - | - | 5.46B | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 16.24B | 16.81B | 7.25B | 17.92B |
Operating expense | 16.24B | 16.81B | 18.34B | 17.92B |
Total operating expenses | 48.72B | 49.95B | 65.58B | 56.88B |
Operating income | 11.50B | 15.39B | 18.57B | 21.91B |
Other non operating income | -17.00M | 165.00M | -358.00M | 272.00M |
EBT including unusual items | 11.65B | 16.73B | 19.38B | 23.64B |
EBT excluding unusual items | 12.09B | 17.01B | 19.57B | 23.82B |
Income tax expense | 2.70B | 4.27B | 4.50B | 6.49B |
Effective tax rate | 23.15% | 25.54% | 23.23% | 27.45% |
Other operating expenses | - | - | - | - |
Net income | 8.94B | 12.22B | 14.66B | 16.84B |
Net profit margin | 14.84% | 18.70% | 17.43% | 21.38% |
Earnings per share | - | - | - | - |
Interest and investment income | 528.00M | 295.00M | 291.00M | 996.00M |
Interest expense | -84.00M | -71.00M | -103.00M | -183.00M |
Net interest expenses | 444.00M | 224.00M | 188.00M | 813.00M |
Depreciation and amortization charges | - | - | 5.62B | - |
EBITDA | 15.12B | 19.58B | 22.93B | 25.53B |
Gain or loss from assets sale | 438.00M | 281.00M | 312.00M | 96.00M |